115 related articles for article (PubMed ID: 28880059)
1. Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches.
Baldan F; Mio C; Allegri L; Passon N; Lepore SM; Russo D; Damante G
Minerva Endocrinol; 2018 Sep; 43(3):285-293. PubMed ID: 28880059
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas.
Rodrigues RF; Roque L; Rosa-Santos J; Cid O; Soares J
Br J Cancer; 2004 Jan; 90(2):492-6. PubMed ID: 14735198
[TBL] [Abstract][Full Text] [Related]
3. Gene-expression profiling in differentiated thyroid cancer--a viable strategy for the practice of genomic medicine?
Weber F; Eng C
Future Oncol; 2005 Aug; 1(4):497-510. PubMed ID: 16556026
[TBL] [Abstract][Full Text] [Related]
4. DNA copy number changes in thyroid carcinoma.
Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
Zitzelsberger H; Thomas G; Unger K
Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
[TBL] [Abstract][Full Text] [Related]
6. A Novel Diagnostic Method for Thyroid Follicular Tumors Based on Immunofluorescence Analysis of p53-Binding Protein 1 Expression: Detection of Genomic Instability.
Otsubo R; Matsuda K; Mussazhanova Z; Sato A; Matsumoto M; Yano H; Oikawa M; Kondo H; Ito M; Miyauchi A; Hirokawa M; Nagayasu T; Nakashima M
Thyroid; 2019 May; 29(5):657-665. PubMed ID: 30929573
[No Abstract] [Full Text] [Related]
7. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
[TBL] [Abstract][Full Text] [Related]
8. Thyroid neoplasms of follicular cell derivation: a simplified approach.
Asa SL; Mete O
Semin Diagn Pathol; 2013 Aug; 30(3):178-85. PubMed ID: 24144287
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide appraisal of thyroid cancer progression.
Wreesmann VB; Ghossein RA; Patel SG; Harris CP; Schnaser EA; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
Am J Pathol; 2002 Nov; 161(5):1549-56. PubMed ID: 12414503
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization.
Miura D; Wada N; Chin K; Magrane GG; Wong M; Duh QY; Clark OH
Thyroid; 2003 Mar; 13(3):283-90. PubMed ID: 12729478
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
Pallante P; Visone R; Croce CM; Fusco A
Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
[TBL] [Abstract][Full Text] [Related]
13. [Update on differenciated thyroid carcinoma].
Karayan L; Hadjadj S; Larsen CJ; Maréchaud R; Kraimps JL
Bull Cancer; 2002 Jan; 89(1):113-23. PubMed ID: 11847033
[TBL] [Abstract][Full Text] [Related]
14. Management of follicular tumors of the thyroid.
Wang TS; Roman SA; Sosa JA
Minerva Chir; 2007 Oct; 62(5):373-82. PubMed ID: 17947948
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Acquaviva G; Visani M; Repaci A; Rhoden KJ; de Biase D; Pession A; Giovanni T
Histopathology; 2018 Jan; 72(1):6-31. PubMed ID: 29239040
[TBL] [Abstract][Full Text] [Related]
16. Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.
Da Silva L; James D; Simpson PT; Walker D; Vargas AC; Jayanthan J; Lakhani SR; McNicol AM
Endocr Pathol; 2011 Jun; 22(2):103-7. PubMed ID: 21499728
[TBL] [Abstract][Full Text] [Related]
17. Pathology and genetics of thyroid carcinoma.
DeLellis RA
J Surg Oncol; 2006 Dec; 94(8):662-9. PubMed ID: 17131411
[TBL] [Abstract][Full Text] [Related]
18. Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
Lee JJ; Au AY; Foukakis T; Barbaro M; Kiss N; Clifton-Bligh R; Staaf J; Borg A; Delbridge L; Robinson BG; Wallin G; Höög A; Larsson C
Endocr Relat Cancer; 2008 Sep; 15(3):801-15. PubMed ID: 18753363
[TBL] [Abstract][Full Text] [Related]
19. Genomic Hallmarks of Thyroid Neoplasia.
Giordano TJ
Annu Rev Pathol; 2018 Jan; 13():141-162. PubMed ID: 29083981
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
Afkhami M; Karunamurthy A; Chiosea S; Nikiforova MN; Seethala R; Nikiforov YE; Coyne C
Thyroid; 2016 Feb; 26(2):242-7. PubMed ID: 26422023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
